Methylphenidate Hydrochloride
NDC 64980-223, Methylphenidate Hydrochloride, tablet, chewable, from Rising Pharma Holdings, Inc..
- Product NDC
- 64980-223
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205756
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/64980-223 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHYLPHENIDATE HYDROCHLORIDE10 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64980-223-01 | 64980022301 | 100 TABLET, CHEWABLE in 1 BOTTLE (64980-223-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e5cb0740-813f-4dce-8c29-d7680c66e77cNADAC price for package 64980022301
GET /v1/drugs/nadac/64980022301
Use it
Look up 64980-223 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64980-223 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64980-223. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.